Activated Factor VII–Antithrombin Complex, a Biomarker of Tissue Factor-Related Pathways in Different Clinical Settings: A Narrative Review from Cardiovascular Diseases to Cancer
Diagnostics · 06.08.2024 · 14 (16) · 1711
DOI: 10.3390/diagnostics14161711 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 06.08.2024. Verfasst von Sara Moruzzi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Verona, 37134 Verona, Italy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PRIN 2022, Italian Ministry of University and Research (MUR), PRIN 2022.
Abstract (Originalsprache)
Tissue factor (TF) is a transmembrane glycoprotein that represents the fundamental physiological initiator of the coagulation cascade through its interaction with factor VII. TF belongs to the cytokine receptor protein superfamily and contributes to the transduction of cellular signaling. Therefore, TF-related pathways are involved in multiple pathophysiological processes, not only in coagulation/thrombosis but in a wider mechanisms’ panorama, ranging from infective to neoplastic diseases. Consistently, the measurement of TF activity could have a diagnostic and/or prognostic meaning in different clinical conditions. However, the transmembrane localization, the expression on different cellular types and circulating extracellular vesicles, and the different conformations (encrypted and decrypted) and variants (such as the soluble alternatively spliced TF) hamper TF assessment in clinical practice. The activated factor VII-antithrombin (FVIIa–AT) complex is proposed as an indirect biomarker of the TF–FVIIa interaction and, consequently, of the functionally active TF expression. In this narrative review, we evaluate the clinical studies investigating the role of plasma concentration of FVIIa–AT in health and disease. Although without conclusive data, high FVIIa–AT concentrations predict the worst clinical outcomes in different pathologic conditions, such as cardiovascular disease and cancer, thereby suggesting that overactivation of TF-related pathways may play an unfavorable role in various clinical settings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, University of Verona, 37134 Verona, Italy.
ORCID-Profile: Annalisa Castagna, Patrizia Pattini, Francesca Pizzolo, Simonetta Friso, Nicola Martinelli
Förderung
- PRIN 2022
- Italian Ministry of University and Research (MUR), PRIN 2022
Zitieren
APA
Moruzzi, S., Castagna, A., Spizzo, M., Udali, S., Pattini, P., Pizzolo, F., Friso, S., & Martinelli, N. (2024). Activated Factor VII–Antithrombin Complex, a Biomarker of Tissue Factor-Related Pathways in Different Clinical Settings: A Narrative Review from Cardiovascular Diseases to Cancer. Diagnostics, 14(16), 1711. https://doi.org/10.3390/diagnostics14161711
Vancouver
Moruzzi S, Castagna A, Spizzo M, Udali S, Pattini P, Pizzolo F, et al. Activated Factor VII–Antithrombin Complex, a Biomarker of Tissue Factor-Related Pathways in Different Clinical Settings: A Narrative Review from Cardiovascular Diseases to Cancer. Diagnostics. 2024;14(16):1711. doi:10.3390/diagnostics14161711
BibTeX
@article{Moruzzi2024,
author = {Moruzzi, Sara and Castagna, Annalisa and Spizzo, Marianna and Udali, Silvia and Pattini, Patrizia and Pizzolo, Francesca and Friso, Simonetta and Martinelli, Nicola},
title = {Activated Factor VII–Antithrombin Complex, a Biomarker of Tissue Factor-Related Pathways in Different Clinical Settings: A Narrative Review from Cardiovascular Diseases to Cancer},
journal = {Diagnostics},
year = {2024},
volume = {14},
number = {16},
pages = {1711},
doi = {10.3390/diagnostics14161711}
}
EUVIMED